Family and twins studies have suggested that genetic factors are involved in the development of substance use disorders. Several unrelated case/control association studies have reported associations of the GABA A subunit genes on 5q33 with the development of alcohol dependence. We hypothesized that these particular GABA A subunit genes also contribute to the development of methamphetamine use disorder. To test our hypothesis, we recruited cases using a series of questionnaires. Among the polymorphic SNPs, significant differences between cases and controls were identified in the female sample in the rs2279020 of the GABA A a1 subunit gene, and the novel SNP rs4480617 in the GABA A g2 subunit gene. No associations were found in the male sample. Further haplotype analysis identified several marker blocks significantly associated with methamphetamine use disorder in females; each block consists of the rs4480617. Our study provides preliminary evidence that the GABA A subunit genes on 5q33 may preferentially contribute to methamphetamine use disorder in females.
INTRODUCTION
Amphetamine-type stimulants have high dependence liability and abuse of these compounds has been a worldwide health problem since the World War II. 1, 2 There is increasing evidence that substance use disorders are familial and that genetic factors explain a substantial degree of the familial aggregation. 3 Grove et al 4 studied a sample of 32 pairs of monozygotic twins reared apart, and reported that inherited factors explained 45% of the variance in drug abuse and dependence. Pickens et al 5 found that the variance attributable to genetic factors in abuse of illicit drugs is 31% in males and 22% in females. Similarly, Tsuang et al 6 reported that genetic factors account for 34% of the variance in the individual's risk of developing a drug use disorder; for stimulant abuse, 44% of the variance is attributable to genetic factors. The pairwise concordance rate for stimulant abuse was 14.1% for monozygotic twins and 5.3% for dizygotic twins. 7 The supporting evidence is also derived from animal studies. For example, knockout of the dopamine D4 receptor gene in mice result in animals that are supersensitive to several substances, including methamphetamine. 8 For the GABA A a1 knockout mice, administration of amphetamine sulfate caused an increase in nonlocomotor stereotyped activity (repetitive head bobbing, sniffing, vacuous chewing and rearing), but not in locomotion. 9 Although there have been many human studies examining the genetic contribution to specific substance use, few have examined the genetic contribution to the use of, or dependence on, amphetamine-related compounds. This may be due to the fact that these synthetic chemicals are normally used with other substances. To our knowledge, three genetic association studies, two of a Chinese population in Taiwan and one of a Caucasian population in Czech Republic, have reported no associations between the several candidate genes and methamphetamine use disorder. [10] [11] [12] The g-aminobutyric acid (GABA) inhibitory systems may be a common pathway to several kinds of neurological and psychiatric disorders. GABA is the major inhibitory neurotransmitter of the mammalian brain; it mediates its effects via specific interaction with integral membrane proteins, the GABA receptors. [13] [14] [15] [16] Several case/control association studies have suggested that the GABA A subunit gene cluster on 5q33, namely the GABA A b2, GABA A a6, GABA A a1 and GABA A g2 subunit genes, may play a role in the development of alcoholism in different ethnic populations. [17] [18] [19] [20] The association of these genes and alcoholism appears to be different between populations and clinical phenotypes. For example, the GABA A g2 subunit gene is associated with alcoholism comorbid with antisocial personality disorder in a Japanese population. 17 These findings suggest that the GABA A g2 subunit gene may play a more specific role in the development of antisocial behavior or generally, the development of substance dependence with antisocial behavior.
Here, we explored the possible contributions of the GABA A subunit genes on 5q33 in methamphetamine use disorder. We examined 11 single-nucleotide polymorphisms (SNPs) located across the GABA A subunit gene cluster on 5q33, including eight previously reported, [17] [18] [19] [20] [21] [22] [23] [24] two extracted from the dbSNP of National Center for Biotechnology Information and one found in the 5 0 -untranslated region (5 0 -UTR) of the GABA A g2 subunit gene.
RESULTS
None of the genotype distributions in the male or female control groups deviated from that expected by HWE. Five SNPs that we examined are not polymorphic. These include rs1052804 at exon1 (all subjects examined) and rs2229945 at exon11 (66 controls examined) of the GABA A b2 subunit gene, Pro385Ser at exon8 (all subjects examined) of the GABA A a6 subunit gene, Ala322Asp at exon9 (66 controls examined) of the GABA A a1 subunit gene and Lys289Met at exon8 (all subjects examined) of the GABA A g2 subunit gene.
Genotype distributions of the polymorphic SNPs in male cases and controls are listed in Table 2 , and those of females are listed in Table 3 . We found no associations between the SNPs and methamphetamine use disorder in males, either by allelic or allele positivity w 2 statistics. However, the results are quite different in females: significant differences were Sequences in parentheses are to increase PCR sensitivity according to Kaboev et al. 49 We marked the relative positions of the SNPs according to the mRNA maps; for intronic SNP, we marked according to the genomic maps.
found in rs2279020 (P allelic ¼0.0491, P positivity ¼0.2366) of the GABA A a1 subunit gene and rs4480617 (P allelic ¼0.0049, P positivity ¼0.0077) of the GABA A g2 subunit gene. Further two-by-two, three-by-three, four-by-four, five-by-five and six-by-six haplotype analyses using the FASTEHPLUS demonstrated no haplotype frequency differences between cases and controls in the male sample (data not shown). On the other hand, differences in haplotype frequency between cases and controls were identified in females. The haplotype blocks significantly different in both the w 2 statistics for heterogeneity model and 1000 permutations are b2-rs2229944/g2-rs4480617 (0.0310, 0.0120), a6-rs4480562/ g2-rs4480617 (0.0156, 0.0150), a1-rs2279020/g2-rs4480617 (0.0166, 0.0180), g2-rs4480617/g2-rs211014 (0.0327, 0.0340), b2-rs2229944/a6-rs4480562/g2-rs4480617 (0.039, 0.019) and b2-rs2229944/a1-rs2279020/g2-rs4480617 (0.0242, 0.0140). The main feature of these haplotype blocks is that they all consist of rs4480617, the novel SNP located at nucleotide-69 in the 5 0 -UTR of the GABA A g2 subunit gene. To investigate different association patterns between male and female samples, we compared the allele distributions between male cases and female cases, and male controls and female controls. A significant difference was identified in rs4480617 of the GABA A g2 subunit gene between male and female cases (P¼0.02290) and in rs2279020 of the GABA A a1 subunit gene between male controls and female controls (P¼0.0110). Allele positivity w 2 tests were not performed because susceptible alleles cannot be defined in this scenario.
DISCUSSION
Research on the GABA A subunit genes on 5q33 suggests that they may contribute to the development of alcohol dependence. While some unrelated case/control association studies reported associations between the GABA A subunit genes on 5q33 in different ethnic populations, [17] [18] [19] [20] transmission disequilibrium tests by Song et al 25 reported no evidence of associations between two genetic polymorphisms in the GABA A a6 and GABA A a1 subunit genes with the development of alcohol dependence in a Caucasian sample collected for the Collaborative Study on the Genetics of Alcoholism (COGA). Therefore, the findings remain controversial. For the last few years, quantitative trait loci (QTL), gene knockin (substituting a part of a gene with a desired mutation without disrupting the overall reading frame) and knockout studies of the GABA A b2, GABA A a6, GABA A a1 and GABA A g2 subunit genes in animals have provided information on the role of these genes in the pharmacological and behavioral responses of several sedatives, hypnotics and potentially addictive substances. One of these earliest studies was conducted by Buck et al 26 in 1999 identifying several loci on mouse chromosomes 1, 2, 4 and 11, potentially related to alcohol withdrawal severity by scoring the severity of handling-induced convulsions. The QTL on mouse chromosome 11 located 16-20 cM from the centromere corresponds to human chromosome 5q32-q35 containing the GABA A b2, GABA A a6, GABA A a1 and GABA A g2 subunit genes. Generally speaking, knockout of these genes causes a lack of the coded subunits, induces compensatory GABA A subunit expressions and changes pharmacological actions of specific drugs; 27-38 knockouts of these genes are not vital to life, except the GABA A g2 subunit gene. 29 Among these studies, Reynolds et al 33 provides a direct evidence that the GABA A a1 subunit gene is involved in the nonlocomotor stereotyped activity (repetitive head bobbing, sniffing, vacuous chewing and rearing) during amphetamine sulfate administration. An observation worth mentioning here is that, while there was no difference of pentobarbital action between wild types and the b2À/À and a1À/À mice, the duration of loss of righting reflex produced by ethanol was decreased in male mice for both null types; no differences were observed in ethanol-induced sleep in female mice. 36 These suggest that some genetic effects of the GABA subunit genes can be gender specific. Unfortunately, none of these animal studies examined substance addiction behavior directly.
We agree that the comorbidity of alcohol dependence in methamphetamine users may account for the apparent association in this study (see Chen et al 39 ); however, as the size of the sample is too small for a reliable statistical analysis, we cannot provide further information at this time. For the same reason mentioned above and the argument of multiple comparisons, we did not estimate the variables of early onset, binge use, duration of use, etc, independently. Clustering phenotypes for further statistical evaluation may resolve the argument of multiple comparisons when many variables are of interest. This will be taken up in our future study.
Substance abuse is a male-dominated disorder, with upwards of 70-80% of people abusing drugs being male. 40 Some believe that the clinical features of female drug abusers are more homogeneous than those of male drug abusers, but this notion might not be practical. It may be closer to the fact to state that gender plays a role in the development of different substance dependences, and the clinical features are different between the two genders. For example, a survey of substance use disorders among adolescents in Taiwan by Chong et al 41 reported that disruptive behavior disorders in male addicts are 13 times higher than in females; on the other hand, a study investigating heroin addicts hospitalized for detoxification in Taiwan reported significantly more unemployment and younger onset among female patients than in male patients. 42 Nevertheless, Gerner's study indicates that amphetamine may be more effective as an antidepressant in females or the elderly than in males. 43 This may partly explain the association in females, but not males in this study.
Our current study identified associations of rs2279020 of the GABA A a1 subunit gene and rs4480617 of the GABA A g2 subunit gene with methamphetamine use disorder in females, but not in males. While the finding of gender difference in this study is not clear, it should be noted here that this is not uncommon in animals (eg, Blednov et al 36 ) and human studies (eg, Bell et al 44 ). Nevertheless, this should be interpreted with caution as such difference may be caused by biased sampling or simply, a matter of chance. It is worth noting that only one study of alcohol dependence found an association with an SNP conferring aminoacid changes at the GABA A subunit genes on 5q33, 20 while the rest reported associations with SNPs conferring no amino-acid changes; [17] [18] [19] we found the reported SNPs conferring amino-acid changes [21] [22] [23] [24] not polymorphic in this study. To further this research, additional SNPs should be identified within this gene cluster and these should be combined using haplotype analysis. This will provide more insight into the complexity of the GABA A receptor genes in methamphetamine use disorder.
MATERIALS AND METHODS

Subjects
This study was approved by the Ethics Committee of the Bethlem Royal Hospital and the Maudsley Hospital, London, and the National Science Council, Taiwan. CKC and his associates interviewed methamphetamine users admitted to the Taipei City Psychiatric Center (TCPC) and those arrested and held in the Taipei Detention Center (TDC). Subjects meeting DSMIV clinical diagnosis of methamphetamine abuse were investigated in advance. The Diagnostic Interview for Genetic Studies-Chinese version (DIGS-C), the Family Interview for Genetic Studies-Chinese version (FIGS-C), the scales for Premorbid Social Adjustment and the Premorbid Schizoid and Schizotypal Traits were used in the interviews. The original purpose of CKC's study was to investigate the predisposing factors to methamphetamineinduced psychosis and the results demonstrate that subjects with methamphetamine-induced psychosis may be classified as a distinct group from methamphetamine users. 39 Details of the sampling method and exclusion criteria are mentioned in their work. As the size of the methamphetamine-induced psychosis sample is rather small at this status and may have a different genetic background, here we only examined methamphetamine users without psychosis and the controls. Also, with respect to the possible difference in genetic effects and recombination rate during meiosis between males and females, we stratified the sample according to gender. The mean age and standard deviation of the 142 male methamphetamine users is 28.7377.14, with a minimum of 18 years and a maximum of 52 years. For the 106 female methamphetamine users, the mean age and standard deviation is 25.2976.23, with a minimum of 18 years and a maximum of 48 years. A total of 248 male and 189 female control subjects were gathered from staff and medical students at the TCPC, staff from pharmacy companies, volunteers at a blood donor station and staff at an electricity company. The mean age and standard deviation of the male controls is 35.1379.93, with a minimum of 19 and a maximum of 57; of female controls is 32.93710.14, with a minimum of 17 and a maximum of 57. The control subjects were interviewed by psychiatrists, and those with delusional ideation and histories of methamphetamine use were excluded. Control subjects with other illicit drug uses were also excluded, but we did not investigate their histories of tobacco, alcohol and other legal drug uses. All methamphetamine users were requested to declare their ethnicities and a few Native Taiwanese were identified. As we were not able to obtain ethnic information from the controls, we did not exclude 12 Native Taiwanese from the case group, as such an exclusion would not reduce the possibility of possible population stratifications.
Genotyping Methods
We examined 11 single SNPs across the four GABA A subunit genes on 5q33. Among these SNPs, eight were described in previous reports, [17] [18] [19] [20] [21] [22] [23] [24] two were extracted from the dbSNP of National Center for Biotechnology Information and one was identified in this study. Screening and genotyping methods for the novel SNP are described below. Essential information of all SNPs examined is shown in Table 1 . (40 s), with a final extension of 10 minutes at 721C. Cold SSCP analysis was performed by denaturing 10 ml of the PCR product as described elsewhere, 45 and assayed on a 20 Â 20 Â 0.08 cm 3 nondenaturing polyacrylamide gel (20%, 49:1) at 4B61C, 300 V for 24 h. Sequences of a few subjects with different shifting bands were determined on an ABI-3100 sequencer (figure not shown) and a C-T point substitution at nucleotide-69 (referred to position on mRNA map NM_000816) was identified. The data were submitted to the dbSNP and identification number rs4480617 was assigned.
A MseI RFLP assay was developed to facilitate the genotyping work. A sequence-modified forward primer (nucleotide-22 of the primer was modified from T to G, underlined), 5 0 -ATC TCT GCC CCC TGA ATA GTA AT-3 0 and the reverse primer mentioned above were used to amplify a 285 bp PCR fragment from nucleotide-43 to -327. The purpose of nucleotide modification in the forward primer is to remove the MseI restriction site within the primer because the site reduces the size differences. The 30 ml PCR contained PCR buffer, a higher MgCl 2 concentration at 6.5 mM, 0.2 mM dNTPs, 30 pmol of each primer, 1 U of DNA Taq polymerase and 25 ng of genomic DNA. After an initial 3 min of denaturation at 951C, there followed 40 cycles of 951C (20 s), 581C (15 s) and 721C (35 s) with a final extension of 10 min at 721C. The MseI restriction enzyme digests TTAA. If the nucleotide-69 is T (TTAA), the restriction enzyme cuts the 285 bp fragment into two fragments of 258 and 27 bp. If the nucleotide-69 is C (CTAA), the PCR fragment remains uncut. The genotype data were obtained by assay on 2.5% agarose gels.
Hardy-Weinberg Equilibrium
Deviation from the Hardy-Weinberg equilibrium (HWE) was estimated by exact test using a Monte Carlo algorithm-based program developed by Guo and Thompson. 46 A two-tailed type I error rate of 5% was chosen for the analyses.
Individual v
2 Statistics A recent simulation study by Ohashi et al 47 demonstrated that a w 2 statistic approach applied to allele frequency tables was suitable for recessive, multiplicative and additive modes of inheritance, while when applied to allele positivity tables it was suitable for dominant and additive modes of inheritance. The combined use of both tests does not inflate the type I error rate greatly (0.08 at most) under the null hypothesis of no association. We adopted this strategy as recommended to examine each polymorphic SNPs because it retains a good sensitivity for detecting an association, while protecting against false-positive associations. The allele positivity mentioned above is actually 'susceptible allele positivity', but not 'protective allele positivity'. That is to say, after knowing the susceptible allele (the allele that is more frequent in cases than in controls), those homozygous for the 'susceptible genotype' were merged with the heterozygotes and this combined sample compared with the nonsusceptible homozygous genotype group. Analysis of the protective allele (the allele that is more frequent in controls than in cases) was not conducted because the inflation of type I error rate by performing both susceptible and protective allele positivity w 2 tests is not known.
Model-free Analysis and Permutation Tests FASTEHPLUS, a computer program performing model-free analysis and permutation tests by log-likelihood ratio w 2 statistics, 48 was used to compare haplotype frequencies between cases and controls. It should be noted that the program deletes all data of each subject whenever there is a missing value and therefore, loss of information is expected. This occurs when the program is set to increase the total of markers of each marker block and compare the frequency differences between cases and controls. To maintain the information, we used the simultaneous analysis function of the FASHEHPLUS to determine the 'rough' P-values, then manually set the program to compare haplotype frequencies between the cases and controls for each haplotype within the level where Pr0.10, one combination only at a time. By doing so, all available data were analyzed, while unnecessary extended haplotype analyses were avoided. Empirical P-values were also obtained from the FASHEHPLUS for those marker blocks in which their haplotype frequencies were significantly different between cases and controls, by permuting the test 1000 times.
